Antidiabetic Therapy
Mostrando 1-12 de 18 artigos, teses e dissertações.
-
1. Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
SUMMARY OBJECTIVE: Pathological destruction of insulin signaling molecules such as insulin receptor substrate, especially due to the increase in suppressors of cytokine signaling molecules, has been demonstrated in experimental diabetes. The contribution of suppressors of cytokine signaling proteins to the development of insulin resistance and the effects o
Revista da Associação Médica Brasileira. Publicado em: 2023
-
2. The first series of cases of ketosis-prone type 2 diabetes (flatbush diabetes) in Brazilian adults
SUMMARY Ketosis-prone type 2 diabetes (KPD) is an emerging form of diabetes mellitus characterized by unprovoked ketoacidosis, absence of autoimmunity and beta-cell dysfunction. The KPD may improve after initial glycemic compensation and evolve to exogenous insulin independence, most cases were observed in populations with African or Hispanic backgrounds. We
Arch. Endocrinol. Metab.. Publicado em: 2021-04
-
3. Chlorophyll treatment combined with photostimulation increases glycolysis and decreases oxidative stress in the liver of type 1 diabetic rats
Photodynamic therapy (PDT) promotes cell death, and it has been successfully employed as a treatment resource for neuropathic complications of diabetes mellitus (T1DM) and hepatocellular carcinoma. The liver is the major organ involved in the regulation of energy homeostasis, and in pathological conditions such as T1DM, changes in liver metabolic pathways re
Braz J Med Biol Res. Publicado em: 2020-01
-
4. Scientometrics on interventions used for adherence of hypertension and diabetes therapies
RESUMO Objetivo Identificar as intervenções utilizadas para melhorar a adesão de terapias medicamentosas e não medicamentosas de pacientes hipertensos e diabéticos. Métodos Estudo cienciométrico realizado nos meses de fevereiro e março de 2018, utilizando os termos “intervenções para melhorar a adesão à terapia do diabetes”, “intervençõ
Einstein (São Paulo). Publicado em: 13/12/2019
-
5. Beliefs related to oral antidiabetic use among individuals with diabetes
Resumo Objetivo: Identificar as crenças relacionadas ao uso de antidiabético oral em pessoas com diabetes mellitus tipo 2, com base na Theory of Planned Behavior. Método: Estudo descritivo com abordagem quantiqualitativa, realizado com 32 participantes em uso de antidiabético oral. Os dados foram coletados por meio de formulário com perguntas abertas
Esc. Anna Nery. Publicado em: 24/10/2019
-
6. Role of Adiponectin in prostate cancer
ABSTRACT Obesity is defined as a chronic and excessive growth of adipose tissue. It has been associated with a high risk for development and progression of obesity-associated malignancies, while adipokines may mediate this association. Adiponectin is an adipose tissue-derived adipokines, with significant anti-diabetic, anti-inflammatory, anti-atherosclerotic
Int. braz j urol.. Publicado em: 27/05/2019
-
7. Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review
RESUMO Os inibidores do cotransportador de sódio-glicose do tipo 2 (SGLT2i) são medicamentos que atuam mantendo a glicosúria. Estudos recentes têm demonstrado efeitos promissores desses no tratamento de diabetes mellitus tipo 2 (DM2). No entanto, pode haver um risco aumentado de desenvolver infecções do trato urinário (UTI) em pacientes tratados com e
Rev. Assoc. Med. Bras.. Publicado em: 2019-02
-
8. Inhibition of the sodium-glucose co-transporter 2 in the elderly: clinical and mechanistic insights into safety and efficacy
RESUMO A prevalência da diabetes mellitus tipo 2 em idosos cresceu muito na última década. A redução na sensibilidade à insulina e na capacidade secretora, ganho de peso, sarcopenia e adiposidade elevada são todas alterações metabólicas e corporais comuns entre a população idosa. Essas mudanças críticas favorecem o aumento no risco de hipoglice
Rev. Assoc. Med. Bras.. Publicado em: 2019-01
-
9. Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a common disease associated with metabolic syndrome and can lead to life-threatening complications like hepatic carcinoma and cirrhosis. Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist antidiabetic drug, has the capacity to overcome insulin resistance and attenuate hepatic steatosis but the specific
Braz J Med Biol Res. Publicado em: 14/06/2018
-
10. Unsatisfactory glycemic control in type 2 Diabetes mellitus patients: predictive factors and negative clinical outcomes with the use of antidiabetic drugs
ABSTRACT Many factors can interfere with glycemic control in patients with type 2 diabetes mellitus and this patient group has an increased risk of experiencing drug-related negative outcomes (DNO). The aim of this study was to identify the predictive factors of unsatisfactory glycemic control and DNO in this group of patients. A cross-sectional study was co
Braz. J. Pharm. Sci.. Publicado em: 2016-12
-
11. Fatores associados à nÃo adesÃo do portador de diabetes mellitus tipo 2 aos antidiabÃticos orais / Factors associated with failure of the bearer of diabetes Mellitus type 2 oral antidiabetic
Non-compliance to drug therapy in patients with Diabetes Mellitus type 2 (DM 2) has been observed by health professionals as a major problem for the mantaining the glucose balance. In addition, there are many factors that can influence the non-compliance of patients with DM 2 to oral drugs, and there is no consensus about which ones have the most influence.
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 12/05/2010
-
12. Insulin therapy does not interfere with venous endothelial function evaluation in patients with type 2 diabetes mellitus
INTRODUCTION: Endothelium-dependent dilation is improved in insulin-treated diabetic patients, but this effect is probably due to improved glycemic control. The objective of the present study was to compare endothelium-dependent dilation in patients with well-controlled type 2 diabetes who are or are not using insulin as part of their therapy. METHODS: We st
Clinics. Publicado em: 2010